| Literature DB >> 35070073 |
Pei-Pei Wang1, Chen Lin1, Jiao-Lin Zhou1, Kai-Wen Xu1, Hui-Zhong Qiu1, Bin Wu2.
Abstract
BACKGROUND: The incidence of retrorectal lesions is low, and no consensus has been reached regarding the most optimal surgical approach. Laparoscopic approach has the advantage of minimally invasive. The risk factors influencing perioperative complications of laparoscopic surgery are rarely discussed. AIM: To investigate the risk factors for perioperative complications in laparoscopic surgeries of retrorectal cystic lesions.Entities:
Keywords: Laparoscopic excision; Minimally invasive; Perioperative complications; Retrorectal cystic lesions; Risk factors
Year: 2021 PMID: 35070073 PMCID: PMC8727184 DOI: 10.4240/wjgs.v13.i12.1685
Source DB: PubMed Journal: World J Gastrointest Surg
Figure 1Important steps in the laparoscopic excision technique of retrorectal lesions. A: An incision was made on the left side of the mesorectum; B: Dissection the retrorectal space and mobilized the rectum and mesorectum to the front; C: Dissection the top of the lesion and then dissected the lateral wall, reaching the attachment points of the pelvic floor muscles; D: Protection of the pelvic autonomous nerves and the presacral venous plexus.
Comparisons of the perioperative variables between two groups (n = 62)
|
|
|
| |
|
|
|
| |
| Age, yr | 38.7 ± 12.4 | 35.8 ± 13.8 | 0.387 |
| BMI, kg/m2 | 23.5 ± 3.5 | 23.5 ± 4.2 | 0.963 |
| Type 2 diabetes mellitus | 0.623 | ||
| Yes | 2 (5.1) | 2 (8.7) | |
| No | 37 (94.9) | 21 (91.3) | |
| Hypertension | 0.356 | ||
| Yes | 5 (12.8) | 5 (21.7) | |
| No | 34 (87.2) | 18 (78.3) | |
| ASA classification | 0.744 | ||
| Class I | 27 (69.2) | 15 (65.2) | |
| Class II | 12 (30.8) | 8 (34.8) | |
| Previous abdominal surgery | 0.838 | ||
| Yes | 21 (53.8) | 13 (56.5) | |
| No | 18 (46.2) | 10 (43.5) | |
| Previous treatment | 0.836 | ||
| Yes | 6 (15.4) | 4 (17.4) | |
| No | 33 (84.6) | 19 (82.6) | |
| Symptomatic | 0.602 | ||
| Yes | 16 (41.0) | 11 (47.8) | |
| No | 23 (59.0) | 12 (52.2) | |
| Digital rectal examination | 0.764 | ||
| Positive | 31 (79.5) | 19 (82.6) | |
| Negative | 8 (20.5) | 4 (17.4) | |
| Tumor size, cm | 8.3 ± 3.5 | 8.2 ± 2.8 | 0.882 |
| Operation duration, min | 132.9 ± 66.2 | 139.4 ± 56.9 | 0.694 |
| Blood loss, mL | 61.8 ± 130.0 | 67.4 ± 101.8 | 0.860 |
| Perioperative complications | 0.146 | ||
| Yes | 18 (46.2) | 15 (65.2) | |
| No | 21 (53.8) | 8 (34.8) | |
| Severe complications | 0.520 | ||
| Yes | 4 (10.3) | 3 (13.0) | |
| No | 35 (89.7) | 20 (87.0) | |
| Postoperative length of hospital stay,d | 6.5 ± 3.1 | 7.5 ± 4.4 | 0.296 |
| Readmission within 90 d | 0.524 | ||
| Yes | 3 (7.7) | 1 (4.3) | |
| No | 36 (92.3) | 22 (95.7) | |
Severe complications are defined as perioperative complications of Clavien-Dindo grade 3a or higher.
Comparisons of the perioperative variables between two groups (n = 62)
|
|
|
| |
|
|
|
| |
| Age, yr | 36.6 ± 13.5 | 39.3 ± 11.8 | 0.426 |
| BMI, kg/m2 | 22.8 ± 3.1 | 22.7 ± 2.8 | 0.07 |
| Type 2 diabetes mellitus | 0.289 | ||
| Yes | 3 (12.5) | 1 (2.6) | |
| No | 21 (87.5) | 37 (97.4) | |
| Hypertension | 0.927 | ||
| Yes | 4 (16.7) | 6 (15.8) | |
| No | 20 (83.3) | 32 (84.2) | |
| ASA classification | 0.678 | ||
| Class I | 17 (70.8) | 25 (65.8) | |
| Class II | 7 (29.1) | 13 (34.2) | |
| Previous abdominal surgery | 0.660 | ||
| Yes | 14 (58.3) | 20 (52.6) | |
| No | 10 (41.7) | 18 (47.4) | |
| Previous treatment | 0.027 | ||
| Yes | 7 (29.2) | 3 (7.9) | |
| No | 17 (70.8) | 35 (92.1) | |
| Symptomatic | 0.416 | ||
| Yes | 12 (50.0) | 15 (39.5) | |
| No | 12 (50.0) | 23 (60.5) | |
| Digital rectal examination | 0.924 | ||
| Positive | 20 (83.3) | 30 (78.9) | |
| Negative | 4 (16.6) | 8 (21.1) | |
| Tumor location | 0.258 | ||
| Above-S3 | 13 (54.2) | 26 (68.4) | |
| Under-S3 | 11 (45.8) | 12 (31.6) | |
| Tumor size, cm | 11.5 ± 2.3 | 6.2 ± 1.5 | 0.000 |
| Operation duration, min | 183.6 ± 57.5 | 104.7 ± 43.7 | 0.000 |
| Blood loss, mL | 117.1 ± 175.7 | 30.3 ± 36.7 | 0.004 |
| Perioperative complications | 0.027 | ||
| Yes | 17 (70.8) | 16 (42.1) | |
| No | 7 (29.2) | 22 (57.9) | |
| Severe complications | 0.022 | ||
| Yes | 6 (25.0) | 1 (2.6) | |
| No | 18 (75.0) | 37 (97.4) | |
| Postoperative length of hospital stay,d | 7.7 ± 4.6 | 6.3 ± 2.9 | 0.111 |
| Readmission within 90 d | 0.019 | ||
| Yes | 4 (16.6) | 0 (0.0) | |
| No | 20 (83.3) | 38 (100.0) | |
Severe complications are defined as perioperative complications of Clavien-Dindo grade 3a or higher.
P value < 0.05 indicates the statistical difference.
Univariate and multivariate analyses of factors associated with perioperative complication in all patients (n = 62)
|
|
|
| ||||
|
|
|
|
|
|
| |
| Sex | ||||||
| Male | Reference | |||||
| Female | 5.125 | 0.538-48.718 | 0.155 | |||
| Age, yr | ||||||
| ≤ 60 | Reference | |||||
| > 60 | 0.559 | 0.087-3.605 | 0.541 | |||
| BMI, kg/m2 | ||||||
| ≤ 23 | Reference | |||||
| > 23 | 1.700 | 0.621-4.657 | 0.302 | |||
| ASA | ||||||
| Class I | Reference | |||||
| Class II | 0.826 | 0.284-2.400 | 0.726 | |||
| Type 2 diabetes mellitus | ||||||
| No | Reference | |||||
| Yes | 3.954 | 0.306-51.098 | 0.292 | |||
| Hypertension | Reference | |||||
| No | ||||||
| Yes | 0.591 | 0.126-2.774 | 0.505 | |||
| Tumor diameter, cm | ||||||
| < 10 | Reference | Reference | ||||
| ≥ 10 | 3.339 | 1.122-9.938 | 0.030 | 3.286 | 1.020-10.587 | 0.046 |
| Tumor location | ||||||
| S3↑ | Reference | Reference | ||||
| S3↓ | 2.187 | 0.755-6.341 | 0.149 | 1.991 | 0.655-6.054 | 0.225 |
| Operation duration, min | ||||||
| < 121 min | Reference | |||||
| ≥ 121 min | 1.670 | 0.611-4.568 | 0.318 | |||
| Blood loss, ml | ||||||
| < 25 mL | Reference | |||||
| ≥ 25 mL | 1.923 | 0.699-5.285 | 0.205 | |||
| Previous abdominal surgery | ||||||
| No | Reference | Reference | ||||
| Yes | 0.750 | 0.274-2.051 | 0.575 | 0.667 | 0.227-1.963 | 0.462 |
| Previous treatment | ||||||
| No | Reference | Reference | ||||
| Yes | 1.389 | 0.350-5.505 | 0.640 | 0.938 | 0.208-4.226 | 0.933 |
P value < 0.05 indicates the statistical difference.